Ampoxin 500 Capsule

Item requires a valid prescription

Manufactured By Torrent Pharmaceuticals Limited

Composition Ampicillin 250mg + Cloxacillin 250mg

RS 100.30

MRP RS 118.00

(15% OFF)

Includes all taxes

Package SIZE

( 15 Capsule )

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Ampoxin 500 Capsule

Description:

By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampoxin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Ampoxin interferes with an autolysin inhibitor.

Uses / Indications:

Ampoxin 500 Capsule is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: Bacterial infections, The treatment of beta-hemolytic streptococcal infections, The treatment of pneumococcal infections, The treatment of staphylococcal infections.

Interactions / Warnings:

Before starting AMPOXIN 500MG CAPSULE, please inform your doctor if you have any allergy to any penicillin antibiotics, kidney or liver problems. Do not take AMPOXIN 500MG CAPSULE on your own as self-medication may lead to antibiotic-resistance in which antibiotics fail to act against specific bacterial infections. Consult your doctor immediately if you experience skin rash or prolonged, significant diarrhoea with abdominal pains. Talk to your doctor before taking AMPOXIN 500MG CAPSULE if you had diarrhoea after taking antibiotic or inflammation of the bowel. Avoid taking AMPOXIN 500MG CAPSULE if you are pregnant or breastfeeding unless prescribed by a doctor. Avoid alcohol consumption while taking AMPOXIN 500MG CAPSULE to prevent unpleasant side-effects. Intake of AMPOXIN 500MG CAPSULE may increase risk of jaundice (liver problem) in new born babies so it should be only given after consulting doctor. AMPOXIN 500MG CAPSULE is not recommended for eye use and is contraindicated. AMPOXIN 500MG CAPSULE should not be given to the people with infectious mononucleosis (viral infection with sore throat and fever) leukaemia (blood cancer).

Side Effects:

Two types of allergic reactions to penicillin are noted clinically, immediate and delayed. Immediate reactions usually occur within 20 minutes of administration and range in severity from urticaria and pruritus to angioneurotic edema, laryngospasm, bronchospasm, hypotension, vascular collapse, and death. Such immediate anaphylactic reactions are very rare and usually occur after parenteral therapy but have occurred in patients receiving oral therapy. Another type of immediate reaction, an accelerated reaction, may occur between 20 minutes and 48 hours after administration and may include urticaria, pruritus, and fever. Although laryngeal edema, laryngospasm, and hypotension occasionally occur, fatality is uncommon. Delayed allergic reactions to penicillin therapy usually occur after 48 hours and sometimes as late as 2 to 4 weeks after initiation of therapy. Manifestations of this type of reaction include serum sickness-like symptoms (ie, fever, malaise, urticaria, myalgia, arthralgia, abdominal pain) and various skin rashes. Gastrointestinal Reactions: Nausea, vomiting, diarrhea, stomatitis, black or hairy tongue, and other symptoms of gastrointestinal irritation may occur, especially during oral penicillin therapy. Pseudomembranous colitis has been reported with the use of Dicloxacillin. Therefore, it is important to consider its diagnosis in patients who develop diarrhea in association with Dicloxacillin use. Rare reports have been received during postmarketing surveillance of esophageal burning, esophagitis, and esophageal ulceration, particularly after ingestion of Dicloxacillin capsules with an insufficient quantity of water and/or before going to bed. Nervous System Reactions: Neurotoxic reactions similar to those observed with penicillin G (e.g. lethargy, confusion, twitching, multifocal myoclonus, localized or generalized epileptiform seizures) may occur with large intravenous doses of the penicillinase-resistant penicillins especially in patients with renal insufficiency. Renal Reactions: Renal tubular damage and interstitial nephritis have been associated with the administration of methicillin sodium and infrequently with the administration of nafcillin and oxacillin. Manifestations of this reaction may include rash, fever, eosinophilia, hematuria, proteinuria, and renal insufficiency. Methicillin-induced nephropathy does not appear to be dose-related and is generally reversible upon prompt discontinuation of therapy. Hematologic Reactions: Eosinophilia, hemolytic anemia, agranulocytosis, neutropenia, leukopenia, granulocytopenia, thrombocytopenia, and bone marrow depression have been associated with the use of penicillinase-resistant penicillins. Hepatic Reactions: Hepatotoxicity, characterized by fever, Nausea, and vomiting associated with abnormal liver function tests, mainly elevated SGOT levels, has been associated with the use of oxacillin and Cloxacillin (Ampoxin). Cholestatic hepatitis has been reported rarely. Asymptomatic, transient increases in serum concentrations of alkaline phosphatase, AST (SGOT), and ALT (SGPT) have been reported.

Medicine interaction:

AMPOXIN 500MG CAPSULE may have interaction with antibiotics with sulphonamides (sulfamethoxazol/trimethoprim, sulfadiazine and sulfisoxazole), other antibiotics (azithromycin, gentamycin), anticoagulants (warfarin), anti-gout which decreases uric acid (allopurinol, probenecid), and pain killer (aspirin).